Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
learn more
view full news & events section

Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease


Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON) committed to enabling the study of life-threatening human diseases, has been awarded a subcontract to create genetically engineered miniswine models of sickle cell disease as part of a national resource that could lead to new treatments for the disorder.

https://www.onescdvoice.com/wp-content/uploads/2017/08/intrexon_logo_300x198.png

expertly curated content related to this topic